Love Lifesciences

Love Lifesciences

Early Stage

Revolutionizing the injection experience.

Revolutionizing the injection experience.

Overview

Raised to Date: Raised: $124,000

Total Commitments ($USD)

Platform

Wefunder

Start Date

09/12/2022

Close Date

11/15/2022

Min. Goal
$50,000
Max. Goal
$107,000
Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

Uncapped

Discount

20%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

11/29/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,968

# of Investors

43

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

Overland Park, Kansas

Business Type

Growth

Love Lifesciences is raising funds on Wefunder. The company is revolutionizing the injection experience with its UniPens and MultiPens. UniPen is a single-use injector, while MultiPen is a multiple-use injector, increasing injectable adherence and improving health outcomes. The injectors of Love Lifesciences are easy to use and lead to less pain and anxiety. Love Lifesciences has a rapid FDA studies timeline and won Digital Sandbox KC 2021 and Kansas Department of Commerce KITE Grant 2021. Nick Love and Bradley Hooper founded Love Lifesciences in May 2021. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $107,000. The campaign proceeds will be used for IP protection, research and development, UniPen spring manufacturing, loan repayment, and team payments.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-9,426

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,806

$0

Accounts Receivable

$12,000

$0

Total Assets

$24,336

$0

Short-Term Debt

$0

$0

Long-Term Debt

$25,000

$0

Total Liabilities

$25,000

$0

Financials as of: 09/12/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Love Lifesciences on Wefunder 2022
Platform: Wefunder
Security Type: SAFE

Follow company

Follow Love Lifesciences on Wefunder 2022

Buy Love Lifesciences's Deal Report

Warning: according to the close date for this deal, Love Lifesciences may no longer be accepting investments.

Love Lifesciences Deal Report

Get KingsCrowd’s comprehensive report on Love Lifesciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Love Lifesciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Love Lifesciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge